Purple Biotech Ltd Financial Flexibility Index
Purple Biotech Ltd financial flexibility index. Purple Biotech Ltd (PPBT) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of ILA-1.07 Million (operating CF ILA-1.07 Million minus capex ILA0.00) represents 0% of total liabilities (ILA6.25 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Purple Biotech Ltd (2017–2024)
Financial flexibility index of Purple Biotech Ltd from 2017 to 2024. Historical Financial Flexibility Index trend for Purple Biotech Ltd across 8 annual periods. Explore Purple Biotech Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Purple Biotech Ltd Financial Flexibility Index by Year (2017–2024)
Purple Biotech Ltd financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Purple Biotech Ltd. For the full cash flow conversion analysis, see PPBT operating cash flow.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.48x | ILA-14.37 Million | ILA-14.37 Million | ILA4.13 Million | ▼ -74.8% |
| 2023 | -1.99x | ILA-19.92 Million | ILA-19.93 Million | ILA10.01 Million | ▲ +10.3% |
| 2022 | -2.22x | ILA-16.71 Million | ILA-16.73 Million | ILA7.52 Million | ▲ +25.3% |
| 2021 | -2.97x | ILA-15.14 Million | ILA-15.25 Million | ILA5.09 Million | ▼ -0.9% |
| 2020 | -2.95x | ILA-11.94 Million | ILA-12.09 Million | ILA4.05 Million | ▼ -104.1% |
| 2019 | -1.44x | ILA-5.57 Million | ILA-5.58 Million | ILA3.86 Million | ▲ +36.6% |
| 2018 | -2.28x | ILA-8.46 Million | ILA-8.48 Million | ILA3.72 Million | ▼ -47.7% |
| 2017 | -1.54x | ILA-8.61 Million | ILA-8.63 Million | ILA5.59 Million | — |